OncoMed Pharmaceuticals Inc. (OMED) Declined -5.54% or -0.17 To Price $2.9 On Tuesday


OncoMed Pharmaceuticals Inc. (OMED) declined -5.54% or -0.17 to $2.9. It is near 263708 shares traded, which is 99.68% compare to the average total volume 264566. The market cap of OMED is $109.78 million. The year to date change is -21.48%. The 52 week price range is from $2.9 to $10.89. Price of OMED have changed -7.95% during last week. It have changed -21.08% over last month, -22.86% over last 3 months, -13.52% over last 6 months and -59.76% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for OMED is 4.30. It is 48.28% above current price. The 200-day Moving Averages for OMED is 4.25. It is 46.55% above current price. The 52-week High is 10.89. It is 275.52% from the current price. The 52-week Low is 2.9. The stock hits 52-week low today.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of OMED is 3.34 on 2017-12-29. Short % to float is 2.31%. There are some statistics of OMED. It is has market cap $109.78 million. The share outstanding is 37.86 million. The average volume is 264566. The percent of top 15 Institution holding is 62.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of OMED is 216.92%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of OMED is -41.85%.


Tags:

Share this post